Project Grant HT94252410982
Award Date 9/1/24
Completion Date 8/31/27
Dollars Obligated $386K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92037, USA
Similar Awards
- This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $299,200.00 to Microquin LTD, a biotechnology company in Cambridge, MA, to develop a first-in-class small molecule treatment for epithelial ovarian cancer. The award has a performance period from June 1, 2025 to August 31, 2026. The Military Medical Research and Development program supports advanced biomedical research to transform healthcare for military...
- The Defense Health Agency awarded a $487,407 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Factor Bioscience Inc. in East Cambridge, MA. The grant supports the development of iPSC-derived mesenchymal stromal cells expressing a novel TNF inhibitor for the treatment of rheumatoid arthritis. The award period is from August 1, 2025 to July 31, 2026. The Military Medical Research and Development program funds advanced biomedical research to transform...
- The Defense Health Agency awarded a $2,200,000 Project Grant to Mainehealth, a non-profit healthcare system based in Portland, Maine, under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective from June 15, 2025 to June 14, 2028, will fund research to examine the efficacy of tranexamic acid in reducing capillary leak, tissue edema, and fluid resuscitation requirements after severe burn injuries. This research aims to transform healthcare for military...
- The U.S. Defense Health Agency awarded a $581,220 Project Grant to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, under the Military Medical Research and Development (CFDA 12.420) program. This 3-year grant, effective September 1, 2025 through August 31, 2028, will support research to accelerate understanding and development of treatments for post-traumatic epilepsy through data integration and large-scale, verifiable...
- The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...
- This $812,487 federal Project Grant awarded by the Defense Health Agency supports research at the University of Pennsylvania to modulate liver inflammation and improve outcomes in pancreatic cancer. The grant, provided under the Military Medical Research and Development (CFDA 12.420) program, aims to transform healthcare for military service members, veterans, and the general public through innovative biomedical research. The 3-year project, with a start date of September 30, 2025, will...
- This Project Grant award of $1,155,518.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports in-vivo neuroepigenetics research in combat veterans with repeated blast exposure at the Massachusetts General Hospital (MGH) in Boston, MA. The award, with a performance period from September 1, 2025 to August 31, 2028, will enable advanced biomedical research at MGH, a renowned academic medical center, to investigate innovative approaches...
- The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- The Department of Defense's Defense Health Agency awarded a $860,998 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development (CFDA 12.420) program. This grant will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the general public. Specifically, the research will focus on unraveling the neurophysiology of post-traumatic epilepsy and identifying...
- The Defense Health Agency awarded a $784,602 Project Grant to Dana-Farber Cancer Institute, Inc. (doing business as Dfci) under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from January 2023 to January 2026 to develop next-generation immunotherapy for breast cancer by turning breast cancer cells against themselves. The Military Medical Research and Development program aims to transform military and public health through innovative medical...